Celularity share price logo

Celularity

NASDAQ: CELU

$1.57

-0.53

(-25.24%)

as on

Celularity Stock Performance

as on August 29, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $1.48
    $2.20
    downward going graph

    5.73%

    Downside

    40.13%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.56
    $4.00
    downward going graph

    64.32%

    Downside

    154.78%

    Upside

    downward going graph

Celularity share price movements today

Previous Close
$2.10
Open
$2.16
Volume
10.0M
Market Cap
$25.5M
Day's Low - High
$1.48 - $2.20
52 Week Low - High
$0.56 - $4.00

Celularity Historical Returns

1 Month Return
+ 176.28 %
3 Month Return
+ 111.91 %
1 Year Return
-45.45 %
3 Year Return
-26.57 %
5 Year Return
-97.42 %

Celularity Stock Fundamentals & Key Indicators

Check Celularity market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$25.5M

EPS (TTM)

-3.6905

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.61%

PE Ratio (TTM)

-0.22

Industry PE ratio

-3.0201167315175095

PEG Ratio

0.006077637862931804

EBITDA

-77.6M

Revenue (TTM)

26.6M

Profit Margin

76.04%

Return On Equity TTM

411.46%

Celularity Stock Valuation

Track how Celularity P/E has moved over time to understand its valuation trends.

Celularity in the last 5 years

  • Overview

  • Trends

Lowest (-3.43x)

March 31, 2022

Industry (-3.02x)

December 31, 2025

Today (-0.31x)

December 31, 2025

Highest (12.72x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -0.31x

Celularity vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Celularity with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Celularity image
Celularity
BUY$25.5M-97.42%-0.2276.04%NA
Revolution Medicines image
Revolution Medicines
BUY$46.2B675.69%NA0.00%NA
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
BUY$138.7B173.88%31.9286.04%NA
Moderna image
Moderna
BUY$59.7B-62.65%-7.98-12.57%NA
Regeneron image
Regeneron
BUY$85.8B21.77%19.984.86%0.44%

Stock Returns calculator for Celularity Stock including INR - Dollar returns

The Celularity stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Celularity investment value today

Current value as on today

₹44,400

Returns

-₹55,600

(-55.6%)

Returns from Celularity Stock

-₹59,221 (-59.22%)

Dollar Impact

₹3,621 (+3.62%)

Analyst Recommendation on Celularity Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Celularity. Average target price of $2.5

Celularity Share Price Target

Get share price movements and forecasts by analysts on Celularity.

What analysts predicted

37.2%UPSIDE

Target Price

$2.5

Current Price

$1.57

Analyzed by

7 Analysts

Target

$2.50

Celularity target price $2.5, a slight upside of 37.2% compared to current price of $1.57. According to 7 analysts rating.

Indian Investors' Interest in Celularity Stock

Search interest for Celularity Stock has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-33% versus previous 30 day period

Celularity Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
2
3
12
14
12
9
11
5
5
4
Gross Profit
2
0
2
13
9
5
7
0
3
8
Operating Income
-42
-99
13
-7
-10
-11
-10
-15
-12
-22
EBITDA
-44
-90
-8
-18
-2
-12
-15
-20
-19
-21
Interest Expense
1
0
0
1
1
1
2
1
1
0
Depreciation
2
2
2
2
1
1
1
1
1
1
Income Before Tax
-47
-93
9
-22
-6
-16
-19
-24
-23
-24
Income Tax Expense
-
-
0
-
-
-
-
-
0
0
Net Income
-47
-93
9
-22
-6
-16
-19
-24
-23
-24
Net Profit Margin
72.70%
4.86%
20.67%
88.83%
82.47%
58.23%
68.90%
8.61%
61.81%
208.48%

Celularity Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Mar 2022
Dec 2022
Dec 2023
Mar 2025
Dec 2025
Total Revenue
17
21
14
21
17
22
54
26
Gross Profit
10
14
9
11
-1
6
39
20
Operating Income
0
-264
-151
-109
-25
-192
-38
-61
EBITDA
0
-70
-202
-88
-138
-183
-43
-77
Interest Expense
-
-
2
3
-
3
6
6
Depreciation
4
6
8
8
9
9
7
7
Income Before Tax
0
-267
-212
-100
14
-196
-57
-91
Income Tax Expense
-
-56
-4
0
0
0
-
0
Net Income
0
-211
-208
-100
14
-196
-57
-91
Net Profit Margin
62.66%
70.10%
65.46%
54.76%
-9.40%
29.66%
72.36%
76.04%

Celularity Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-47
-93
9
-22
-6
-16
-19
-24
-23
-24
Operating Cash Flow
-11
-8
-4
-4
-3
0
-2
0
-4
-5
Investing Cash Flow
0
0
0
0
2
0
-
-
-
-
Financing Cash Flow
5
5
0
6
0
0
2
1
3
11
Change in Cash
-5
-2
-4
1
-1
0
0
0
0
6

Celularity Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Mar 2022
Dec 2022
Dec 2023
Mar 2025
Dec 2025
Net Income
-13
5
-208
-100
14
-196
-57
-91
Operating Cash Flow
0
-1
-63
-110
-137
-38
-6
-13
Investing Cash Flow
-31
-286
-12
-5
-5
-4
0
-
Financing Cash Flow
0
288
102
98
119
24
6
18
Change in Cash
-31
0
26
-17
-23
-18
0
5

Mutual Funds that own Celularity Stock

Check out the Mutual Funds with significant holdings in Celularity.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
2.145739%
621105
Fidelity Concord Street Trust
0.46651%
135036
Victory Portfolios III
0.020203%
5848

Global Institutional Holdings in Celularity

Funds
Holdings
Vanguard
2.15%

Celularity News & Key Events

  • img

    Today's Timeline - 27 August

    Thu, 07:18 PM

    -

    Celularity and MuseCell Innovations announce U.S. manufacturing collaboration for Dezawa MuseCells at Florham Park facility.

    Thu, 10:08 PM

    -

    Celularity stock surges 115% after announcing manufacturing agreement with MuseCell Innovations, potentially generating $300 million in purchases.

Insights on Celularity

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, CELU stock has moved up by 162.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 492.7% return, outperforming this stock by 539.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 23.1% return, outperforming this stock by 55.1%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 5 quarters, 18.13M → 4.10M (in $), with an average decrease of 24.6% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -23.07M → -24.36M (in $), with an average decrease of 2.8% per quarter

About Celularity

Celularity Inc., a cellular and regenerative medicine company, focuses on addressing aging-related disease using novel therapies. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It develops off-the-shelf placental-derived allogeneic cell therapy product candidates, including mesenchymal-like adherent stromal cells for diabetic foot ulcer and Crohn's disease. Its therapeutic programs include PDA-001 for the treatment of autoimmune (Crohn's) and degenerative disease; and PDA-002 for treating multiple sclerosis, rheumatoid arthritis, stroke, and diabetic peripheral neuropathy. The company also produces, sells, and licenses products used in surgical and wound care markets, such as Biovance, Biovance 3L, Rebound, Interfyl, and Centaflex; and collects, processes, and stores umbilical cord and placental blood and tissue after full-term pregnancies under the LifebankUSA brand. Celularity Inc. has licensing agreement with Sorrento Therapeutics, Inc. for the development and commercialization of licensed CD19 CAR-T products; and research collaboration services agreement with Regeneron Pharmaceuticals, Inc. to support the research of allogeneic cell therapy candidates. Celularity Inc. was founded in 1998 and is headquartered in Florham Park, New Jersey.
OrganisationCelularity
Headquarters170 Park Avenue, Florham Park, NJ, United States, 07932
IndustryBiotechnology
CEODr. Robert Joseph Hariri M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Celularity

Name

Title

Mr. Steven N. Gordon Esq.

Chief Operating and Administrative Officer & Director

Mr. Carlos Ramirez

SVP of Investor Relations

Mr. Kyle Harold Fletcher Esq.

Chief Legal and Strategy Officer & Corporate Secretary

Sharmila Koppisetti M.D.

Senior Vice President of Clinical Dev. Immunology & Drug Safety

Mr. Tim Wilk

Senior Vice President of Technical Operations

Mr. David Jakob Lemus CPA, M.S., MBA

Treasurer

Dr. Robert Joseph Hariri M.D., Ph.D.

Founder, CEO & Chairman

John Sprague

Acting Chief Financial Officer

FAQs

What is Celularity share price today?

Celularity share price today is $1.57 as on at the close of the market. Celularity share today touched a day high of $2.20 and a low of $1.48.

What is the 52 week high and 52 week low for Celularity share?

Celularity share touched a 52 week high of $4.00 on and a 52 week low of $0.56 on . Celularity stock price today i.e. is closed at $1.57,which is 60.75% down from its 52 week high and 180.31% up from its 52 week low.

What is Celularity's market capitalisation today?

Celularity market capitalisation is $0.00T as on .

How to invest in Celularity Stock (CELU) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Celularity on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Celularity Shares that will get you 0.9554 shares as per Celularity share price of $1.57 per share as on August 29, 2026 at 1:29 am IST.

What is the minimum amount required to buy Celularity Stock (CELU) from India?

Indian investors can start investing in Celularity (CELU) shares with as little as ₹95.368 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.68 in Celularity stock (as per the Rupee-Dollar exchange rate as on ). Based on Celularity share’s latest price of $1.57 as on August 29, 2026 at 1:29 am IST, you will get 6.3694 shares of Celularity. Learn more about fractional shares .

What are the returns that Celularity has given to Indian investors in the last 5 years?

Celularity stock has given -97.42% share price returns and 30.18% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?